Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verucerfont in Female Subjects with Major Depressive Disorder
NCT00733980Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verucerfont in major depressive disorder (MDD), sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
verucerfont
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00733980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733980.